Methadone Market Trends

  • Report ID: 3793
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Methadone Market Trends

Growth Drivers

  • Increasing Application in Heroin Addiction Treatment – Methadone is widely used to reduce addiction or dependency on heroin, morphine, or prescription painkillers. Therefore, increasing application in heroin addiction treatment is one of the growth drivers of this market. As per the latest World Drug Report, every year around 35 million people suffer from Drug disorders.
  • Increasing Geriatric Population – As discussed in the above parts, methadone is a drug or medication that helps in reducing pain after a post-surgery or therapeutic treatment. Also, the medication patients recover from any kind of chronic disease if they are suffering through it. Many times it is seen that people who are above the age of 60 or who belong to the geriatric population end up suffering from chronic disease. Therefore, the increasing geriatric population is driving the growth of this market.  As per a report from the World Health Organization, the geriatric population is expected to become double.
  • Growing Development and Launches in the Field of Methadone – Recently, lots of development and launch have taken place in the field of methadone. Elite Pharmaceutical and Glenmark Pharmaceutical collaborated and introduced methadone hydrochloride tablets in the market that will be used to reduce opioid abuse in patients. 
  • Growing Existence of Chronic Diseases – In the United States around 45% population of the region suffers from chronic diseases.

Challenges

  • Side Effects of Methadone – The rise in side effects, such as constipation, nausea, and vomiting, among others, is one of the factors that is expected to restrict the expansion of the methadone market. Furthermore, the market is likely to face obstacles because of strict government approval.
  • Addictive Nature of Opioids
  • Circulation of Generic Methadone

Methadone Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

7.3%

Base Year Market Size (2023)

USD 160.95 Million

Forecast Year Market Size (2036)

USD 402.24 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3793
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of methadone is assessed at USD 171.52 Million.

The methadone market size was valued at USD 160.95 Million in 2023 and is expected to reach USD 402.24 Million by the end of 2036, registering around 7.3% CAGR during the forecast period i.e., between 2024-2036. The growing demand for methadone rehabilitation of heroin addicts is the major factor driving the market growth.

North America region is likely to gain largest industry share by 2036, driven by increasing cases of drug addiction in the region

Eli Lilly and Company, Sanofi S.A., Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., BioControl Medical, Tianjin Central Pharmaceutical Industry Co., Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample